Revolution Medicines, Inc. (NASDAQ:RVMD) Receives Consensus Rating of Buy from Brokerages

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has received an average rating of “Buy” from the ten ratings firms that are presently covering the company, Marketbeat reports. Ten equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have issued ratings on the stock in […]

Related Keywords

United States ,Hong Kong ,America ,Jeff Cislini ,Raymond James ,Stephen Michael Kelsey ,Piper Sandler ,Tower Research Capital ,Securities Exchange Commission ,Revolution Medicines Inc ,Us Bancorp ,Hong Kong Ltd ,Shell Asset Management Co ,Nasdaq ,Revolution Medicines ,Get Free Report ,Exchange Commission ,General Counsel Jeff Cislini ,Kong Ltd ,Asset Management ,Research Capital ,Get Free ,Revolution Medicines Daily ,